Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: A single-blind randomized preliminary study

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 8, 2013, Pages 4859-4864

  Kong, Moonkyoo ^a   Hong, Seong Eon ^a  

^a Kyung Hee University College of Medicine   (South Korea)

Author keywords

Breast cancer; Epidermal growth factor; Radiation dermatitis

Indexed keywords

EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEIN;

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDY; RADIATION DERMATITIS; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SOUTH KOREA; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EPIDERMAL GROWTH FACTOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIODERMATITIS; RADIOTHERAPY; RECOMBINANT PROTEINS; REPUBLIC OF KOREA; SINGLE-BLIND METHOD;

EID: 84885692840     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.8.4859     Document Type: Article

References (37)

1. Bostrom A, Lindman H, Swartling C, Berne B, Bergh J (2001). Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study. Radiother Oncol, 59, 257-65.
2. Brown GL, Curtsinger L 3rd, Brightwell JR, et al (1986). Enhancement of epidermal regeneration by biosynthetic epidermal growth factor. J Exp Med, 163, 1319-24.
3. Brown GL, Nanney LB, Griffen J, et al (1989). Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med, 321, 76-9.
4. Cohen S (1962). Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem, 237, 1555-62.
5. Dormand EL, Banwell PE,Goodacre TE (2005). Radiotherapy and wound healing. Int Wound J, 2, 112-27.
6. Duncan W, MacDougall RH, Kerr GR, Downing D (1996). Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer. Radiother Oncol, 41, 203-7.
7. Fenig E, Brenner B, Katz A, et al (2001). Topical Biafine and Lipiderm for the prevention of radiation dermatitis: a randomized prospective trial. Oncol Rep, 8, 305-9.
8. Fernando IN, Ford HT, Powles TJ, et al (1996). Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: a prospective study of treatment practice at the Royal Marsden Hospital. Clin Oncol (R Coll Radiol), 8, 226-33.
9. Fisher J, Scott C, Stevens R, et al (2000). Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys, 48, 1307-10.
10. Graham PH, Plant N, Graham JL, et al (2013). A paired, double-blind, randomized comparison of a moisturizing durable barrier cream to 10% glycerine cream in the prophylactic management of postmastectomy irradiation skin care: trans Tasman Radiation Oncology Group (TROG) 04.01. Int J Radiat Oncol Biol Phys, 86, 45-50.
11. Halperin EC, Gaspar L, George S, Darr D, Pinnell S (1993). A double-blind, randomized, prospective trial to evaluate topical vitamin C solution for the prevention of radiation dermatitis. CNS Cancer Consortium. Int J Radiat Oncol Biol Phys, 26, 413-6.
12. Harper JL, Franklin LE, Jenrette JM, Aguero EG (2004). Skin toxicity during breast irradiation: pathophysiology and management. South Med J, 97, 989-93.
13. Hemati S, Asnaashari O, Sarvizadeh M, et al (2012). Topical silver sulfadiazine for the prevention of acute dermatitis during irradiation for breast cancer. Support Care Cancer, 20, 1613-8.
14. Hong JP, Jung HD, Kim YW (2006a). Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers. Ann Plast Surg, 56, 394-8.
15. Hong JP, Kim YW, Jung HD, Jung KI (2006b). The effect of various concentrations of human recombinant epidermal growth factor on split-thickness skin wounds. Int Wound J, 3, 123-30.
16. Hong JP, Kim YW, Lee SK, Kim SH, Min KH (2008). The effect of continuous release of recombinant human epidermal growth factor (rh-EGF) in chitosan film on full thickness excisional porcine wounds. Ann Plast Surg, 61, 457-62.
17. Hymes SR, Strom EA, Fife C (2006). Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol, 54, 28-46.
18. Kirova YM, Fromantin I, De Rycke Y, et al (2011). Can we decrease the skin reaction in breast cancer patients using hyaluronic acid during radiation therapy? Results of phase III randomised trial. Radiother Oncol, 100, 205-9.
19. Lee KK, Jo HJ, Hong JP, et al (2008). Recombinant human epidermal growth factor accelerates recovery of mouse small intestinal mucosa after radiation damage. Int J Radiat Oncol Biol Phys, 71, 1230-5.
20. Lee SW, Jung KI, Kim YW, et al (2007a). Effect of epidermal growth factor against radiotherapy-induced oral mucositis in rats. Int J Radiat Oncol Biol Phys, 67, 1172-8.
21. Lee SW, Moon SY, Kim YH, Hong JP (2007b). The use of recombinant human epidermal growth factor to promote healing for chronic radiation ulcer. Int Wound J, 4, 216-20.
22. Leonardi MC, Gariboldi S, Ivaldi GB, et al (2008). A double-blind, randomised, vehicle-controlled clinical study to evaluate the efficacy of MAS065D in limiting the effects of radiation on the skin: interim analysis. Eur J Dermatol, 18, 317-21.
23. McQuestion M (2006). Evidence-based skin care management in radiation therapy. Semin Oncol Nurs, 22, 163-73.
24. Merchant TE, Bosley C, Smith J, et al (2007). A phase III trial comparing an anionic phospholipid-based cream and aloe vera-based gel in the prevention of radiation dermatitis in pediatric patients. Radiat Oncol, 2, 45.
25. Nanney LB (1990). Epidermal and dermal effects of epidermal growth factor during wound repair. J Invest Dermatol, 94, 624-9.
26. Ogce F, Okcin F, Yaren A, Demiray G (2013). Evaluation of quality of life of breast cancer patient next-of-kin in Turkey. Asian Pac J Cancer Prev, 14, 2771-6.
27. Olascoaga A, Vilar-Compte D, Poitevin-Chacon A, Contreras-Ruiz J (2008). Wound healing in radiated skin: pathophysiology and treatment options. Int Wound J, 5, 246-57.
28. Pinnix C, Perkins GH, Strom EA, et al (2012). Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial. Int J Radiat Oncol Biol Phys, 83, 1089-94.
29. Pommier P, Gomez F, Sunyach MP, et al (2004). Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol, 22, 1447-53.
30. Pourhoseingholi MA, Safaee A, Moghimi-Dehkordi B, et al (2008). Quality of life in breast cancer patients--a quantile regression analysis. Asian Pac J Cancer Prev, 9, 487-90.
31. Ryu SH, Kim YH, Lee SW, Hong JP (2010). The preventive effect of recombinant human growth factor (rhEGF) on the recurrence of radiodermatitis. J Radiat Res, 51, 511-7.
32. Schmuth M, Wimmer MA, Hofer S, et al (2002). Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study. Br J Dermatol, 146, 983-91.
33. Tsang MW, Wong WK, Hung CS, et al (2003). Human epidermal growth factor enhances healing of diabetic foot ulcers. Diabetes Care, 26, 1856-61.
34. Tucker SL, Turesson I, Thames HD (1992). Evidence for individual differences in the radiosensitivity of human skin. Eur J Cancer, 28, 1783-91.
35. Wells M, Macmillan M, Raab G, et al (2004). Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial. Radiother Oncol, 73, 153-62.
36. Williams MS, Burk M, Loprinzi CL, et al (1996). Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys, 36, 345-9.
37. Xie XX, Ouyang SY, Jin HK, et al (2012). Predictive value of XRCC1 gene polymorphisms for side effects in patients undergoing whole breast radiotherapy: a meta-analysis. Asian Pac J Cancer Prev, 13, 6121-8.